Thiamphenicol enteric-coated tablets
A technology of thiamphenicol and enteric-coated tablets, applied in the field of enteric-coated tablets, can solve the problems of low bioavailability and poor targeting
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0029] Example 1 Prescription
[0030] Thiamphenicol inclusion compound: thiamphenicol:α-cyclodextrin is 1.5:4.2
[0031] The application provides an enteric-coated tablet of thiamphenicol, which includes:
[0032] Prescription of thiamphenicol inclusion compound tablet core:
[0033] Thiamphenicol inclusion complex
150 copies
180 copies
25 copies
10 copies
disintegrant
14.5 servings
8 servings
[0034] Enteric coating prescription:
[0035] Polyvinyl phthalate
25 copies
Cellulose acetate trimellitate
60 copies
85% ethanol
Appropriate amount
talcum powder
15 copies
[0036] Wherein the disintegrant is a composition of hydroxypropyl starch and sodium alginate, and the weight ratio of the two is 3.5:11
[0037] Preparation:
[0038] 1. Prepare thiamphenicol inclusion compound according to the...
Embodiment 2
[0046] Thoroughly grind the thiamphenicol and α-cyclodextrin described in Example 1 in 50% ethanol until a uniform paste is formed. After vacuum drying, a white powder is obtained. The solubility of the powder in water is lower than that of unincluded methylsulfone Mycin increased by 13 times.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 